Fig. 4From: Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivoReduction in PVLs in PBMCs from asymptomatic carriers by TARC–PE38. PBMCs obtained from seven asymptomatic carriers (carriers #1–7) were incubated for 5 days in the absence (0 μg/ml, PBS only: blue line) or presence of 10 (green line) or 20 μg/ml TARC–PE38 (red line). The PVL in each culture was then measured with quantitative PCR. The data are presented as copies/100 cells. These results are representative of more than two independent experimentsBack to article page